Step 2 - Expert Review: A licensed provider in the patient's state reviews the intake and recommends a course of action
Metabolic Inflexibility : A disrupted microbiome can make it harder to maintain weight loss and metabolic improvements after discontinuing GLP-1 therapy
Semaglutide STEP trials: the benchmark The STEP (Semaglutide Treatment Effect in People with Obesity) trial program established semaglutide as a legitimate weight loss medication
By tagging the substrates with ubiquitin, E3 ligases provide a platform for protein-protein interactions that can modulate the activity, localization or interaction of the target proteins, thereby triggering different biological signals to regulate a variety of cellular processes including cell cycle, cell division, stress response, DNA repair and apoptosis etc 1,2,3,4
Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control